Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We investigated the molecular basis of the cardiac phenotype in two mouse models at established disease stage (mouse-HCM), and human myectomy tissue (human-HCM). We analyzed the transcriptome in 2 mouse models w...
Guardado en:
Autores principales: | Styliani Vakrou, Yamin Liu, Li Zhu, Gabriela V. Greenland, Bahadir Simsek, Virginia B. Hebl, Yufan Guan, Kirubel Woldemichael, Conover C. Talbot, Miguel A. Aon, Ryuya Fukunaga, M. Roselle Abraham |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e365172126d5471c8bde7c2cc906f5f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014) -
Hypertrophic Cardiomyopathy with a Twist
por: W. Francis, et al.
Publicado: (2021) -
Hypertrophic Cardiomyopathy in South Western Nigeria
por: Amam Mbakwem, et al.
Publicado: (2017) -
Feline hypertrophic cardiomyopathy: an echocardiographic approach
por: Silva,AC, et al.
Publicado: (2013) -
COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Milla E. Arabadjian, et al.
Publicado: (2021)